« Back to Farmacia Journal 3/2020
THE CHALLENGES OF USING PD-L1 AS A PREDICTIVE BIOMARKER AND THE THERAPEUTIC APPROACH IN NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
ADELA PĂTCAȘ 1#, CRISTINA MOGOȘAN 2*, TEODORA GABRIELA ALEXESCU 3#, IOANA ROXANA BORDEA 4, ANCA DANA BUZOIANU 5#, DOINA ADINA TODEA 1
1.“Iuliu Hațieganu” University of Medicine and Pharmacy, Department of Pneumology, Cluj-Napoca, Romania
2.“Iuliu Hațieganu” University of Medicine and Pharmacy, Department of Pharmacology, Physiology and Pathophysiology, Cluj-Napoca, Romania
3.“Iuliu Hațieganu” University of Medicine and Pharmacy, Department of Internal Medicine, Cluj-Napoca, Romania
4.“Iuliu Hațieganu” University of Medicine and Pharmacy, Department of Oral Rehabilitation, Oral Health and Dental Office Management, Cluj-Napoca, Romania
5.“Iuliu Hațieganu” University of Medicine and Pharmacy, Department of Pharmacology, Toxicology and Clinical Pharmacology, Cluj-Napoca, Romania